Owlet to Report Fourth Quarter and Full Year 2025 Financial Results on March 5, 2026

Owlet, Inc. (NYSE: OWLT), a pioneer in smart infant monitoring, is set to announce its financial results for the fourth quarter and full year of 2025 after the market closes on March 5, 2026. The announcement will be followed by a conference call hosted by President and CEO Jonathan Harris and CFO Amanda Twede Crawford at 4:30 p.m. ET. Participants can join the call by dialing 833-470-1428 (domestic) or 646-844-6383 (international), using Access Code 211338. A simultaneous webcast will be available on Owlet's Investor Relations website, with a replay accessible shortly after.

Founded in 2012, Owlet is recognized for its groundbreaking pediatric health platform, offering FDA-cleared and internationally certified wearable monitors that deliver hospital-grade technology right into the home. Their suite of award-winning products includes clinically tested monitoring systems coupled with an integrated video platform and an intuitive mobile app. These tools provide parents with real-time health insights, enhancing peace of mind and supporting their children's well-being and restful sleep.

With over 2.5 million families using Owlet’s monitoring solutions, the company has amassed one of the world’s largest databases of pediatric health and sleep data, which drives ongoing innovations in the field. Owlet's mission is to redefine pediatric wellness standards by seamlessly integrating advanced medical technology with consumer-friendly design, ensuring every baby has the best start in life.

For further information about Owlet and its offerings, visit www.owletcare.com or follow them on LinkedIn and Instagram for updates.

As Owlet, Inc. (NYSE: OWLT) prepares to announce its fourth quarter and full year 2025 financial results on March 5, 2026, investors should closely monitor key indicators and trends in the pediatric health market, as these can influence the company's stock performance in the near term.

Owlet’s position as a pioneer in smart infant monitoring and the unique offerings of its FDA-cleared wearable monitors provide a competitive advantage in a rapidly growing field. The market for pediatric health technology is expanding, fueled by increasing parental concerns about child health and sleep quality. Owlet has already garnered significant trust, reportedly assisting over 2.5 million parents since its inception—a substantial user base that could translate to robust recurring revenue.

Analysts will be keen to assess how Owlet's financial results align with market expectations. Key metrics to watch include revenue growth, customer acquisition costs, and gross margins. Any positive trends in these areas could signal strong demand for Owlet's products and enhance investor confidence.

Furthermore, during the conference call, management's commentary on future growth strategies, potential product launches, and expansion plans will provide insights into Owlet's vision. Investors should also take note of any updates regarding partnerships or collaborations that could enhance Owlet's market presence.

In anticipation of the earnings release, market sentiment around Owlet may fluctuate. Investors might consider positioning themselves based on projected movement, particularly if pre-release indicators suggest a bullish trend. Additionally, monitoring overall market conditions and the broader economic environment the healthcare sector operates within will be crucial to making informed decisions.

In summary, Owlet's forthcoming financial results will serve as an essential barometer for its ongoing performance in the pediatric health space. Stakeholders should keenly analyze the data and insights presented during the earnings call to gauge future prospects.